Position in SIBN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$4,686,765
-$1,151,676 QoQ
Shares Held
371,082
+25.3% QoQ
Ownership
0.837%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SIBN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026ROYCE & ASSOCIATES LP holds $183,504,116 across 22 Medical Devices names. SIBN ranks #13 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMDX |
TransMedics Group, Inc.
|
244,382 | $24,294,014 | |
| 2 | ESTA |
Establishment Labs Holdings Inc.
|
427,472 | $24,271,860 | |
| 3 | AORT |
Artivion, Inc.
|
425,282 | $15,573,826 | |
| 4 | BVS |
Bioventus Inc.
|
1,541,282 | $14,071,904 | |
| 5 | ENOV |
Enovis CORP
|
611,090 | $13,902,297 | |
| 6 | TNDM |
Tandem Diabetes Care Inc
|
696,590 | $13,353,630 | |
| 7 | APYX |
Apyx Medical Corp
|
2,611,224 | $9,635,416 | |
| 8 | CBLL |
Ceribell, Inc.
|
515,720 | $9,453,147 |
All Filings in SIBN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,686,765 | 371,082 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $5,838,441 | 296,067 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,385,390 | 162,051 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,070,802 | 110,032 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,543,748 | 110,032 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,542,200 | 110,000 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,537,800 | 110,000 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $1,874,850 | 145,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,373,650 | 145,000 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,043,550 | 145,000 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,803,680 | 132,000 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,561,360 | 132,000 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $2,596,440 | 132,000 | Shares | Sole | 2023-05-23 | |
| 2022-12-31 | $1,305,600 | 96,000 | Shares | Sole | 2023-05-23 | |
| 2022-09-30 | $1,169,820 | 67,000 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $1,082,400 | 82,000 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,853,200 | 82,000 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $1,821,220 | 82,000 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $3,263,508 | 152,358 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $7,469,656 | 237,358 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $8,073,378 | 253,800 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $20,681,830 | 691,700 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $7,818,112 | 329,600 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,024,942 | 64,300 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||